These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines. Erra EO, Askling HH, Rombo L, Riutta J, Vene S, Yoksan S, Lindquist L, Pakkanen SH, Huhtamo E, Vapalahti O, Kantele A. Clin Infect Dis; 2012 Sep; 55(6):825-34. PubMed ID: 22696017 [Abstract] [Full Text] [Related]
25. Decreases in Both the Seroprevalence of Serum Antibodies and Seroprotection against Japanese Encephalitis Virus among Vaccinated Children. Wang R, Xie L, Gao N, Fan D, Chen H, Wang P, Zhou H, An J. Virol Sin; 2019 Jun; 34(3):243-252. PubMed ID: 30911897 [Abstract] [Full Text] [Related]
29. Is a booster dose necessary in children after immunization with live attenuated Japanese encephalitis vaccine? Choi UY, Lee SY, Kim KH, Kim DS, Choi KM, Cha SH, Kang JH. J Trop Pediatr; 2013 Oct; 59(5):423-5. PubMed ID: 23764540 [Abstract] [Full Text] [Related]
30. A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses. Sohn YM, Tandan JB, Yoksan S, Ji M, Ohrr H. Vaccine; 2008 Mar 20; 26(13):1638-43. PubMed ID: 18294743 [Abstract] [Full Text] [Related]
31. Immunogenicity and safety of Vero cell culture-derived Japanese encephalitis vaccine: a phase 3 study in Chinese infants. Wang H, Wang J, Yan S, Zhao G, Wang S, Tao H, Xu Y, Wu J. Expert Rev Vaccines; 2024 Mar 20; 23(1):958-965. PubMed ID: 39279603 [Abstract] [Full Text] [Related]
34. Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine. Woolpert T, Staples JE, Faix DJ, Nett RJ, Kosoy OI, Biggerstaff BJ, Johnson BW, Sracic M, Fischer M. Vaccine; 2012 Apr 26; 30(20):3090-6. PubMed ID: 22406277 [Abstract] [Full Text] [Related]
36. Persistence of Wild-Type Japanese Encephalitis Virus Strains Cross-Neutralization 5 Years After JE-CV Immunization. Feroldi E, Boaz M, Yoksan S, Chokephaibulkit K, Thisyakorn U, Pancharoen C, Monfredo C, Bouckenooghe A. J Infect Dis; 2017 Jan 15; 215(2):221-227. PubMed ID: 27815383 [Abstract] [Full Text] [Related]
37. Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, double-blinded, randomized trial. Yun KW, Lee HJ, Kang JH, Eun BW, Kim YJ, Kim KH, Kim NH, Hong YJ, Kim DH, Kim HM, Cha SH. BMC Infect Dis; 2015 Jan 08; 15():7. PubMed ID: 25567119 [Abstract] [Full Text] [Related]
39. Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis. Wang SY, Cheng XH, Li JX, Li XY, Zhu FC, Liu P. Hum Vaccin Immunother; 2015 Jan 08; 11(6):1418-25. PubMed ID: 25915588 [Abstract] [Full Text] [Related]